145 related articles for article (PubMed ID: 3375961)
21. Patterns of recurrence in patients with melanoma after radical lymph node dissection.
Nathansohn N; Schachter J; Gutman H
Arch Surg; 2005 Dec; 140(12):1172-7. PubMed ID: 16365238
[TBL] [Abstract][Full Text] [Related]
22. Melanoma patients with positive sentinel nodes who did not undergo completion lymphadenectomy: a multi-institutional study.
Wong SL; Morton DL; Thompson JF; Gershenwald JE; Leong SP; Reintgen DS; Gutman H; Sabel MS; Carlson GW; McMasters KM; Tyler DS; Goydos JS; Eggermont AM; Nieweg OE; Cosimi AB; Riker AI; G Coit D
Ann Surg Oncol; 2006 Jun; 13(6):809-16. PubMed ID: 16604476
[TBL] [Abstract][Full Text] [Related]
23. N-ratio: a novel independent prognostic factor for patients with stage-III cutaneous melanoma.
Rossi CR; Mocellin S; Pasquali S; Pilati P; Nitti D
Ann Surg Oncol; 2008 Jan; 15(1):310-5. PubMed ID: 17987346
[TBL] [Abstract][Full Text] [Related]
24. Natural history of melanoma in 773 patients with tumor-negative sentinel lymph nodes.
Zogakis TG; Essner R; Wang HJ; Foshag LJ; Morton DL
Ann Surg Oncol; 2007 May; 14(5):1604-11. PubMed ID: 17333418
[TBL] [Abstract][Full Text] [Related]
25. [Relation between the prognosis of skin melanomas and the timing of appearance of regional metastases].
Vagner RI; Anisimov VV
Vopr Onkol; 1986; 32(10):21-5. PubMed ID: 3776125
[TBL] [Abstract][Full Text] [Related]
26. Recurrence of cutaneous malignant melanoma after more than 20 years.
Bredgaard R; Lock-Andersen J
J Plast Surg Hand Surg; 2011 Apr; 45(2):113-6. PubMed ID: 21504283
[TBL] [Abstract][Full Text] [Related]
27. [Controversial aspects of stage I skin melanomas].
Cavegn B; Puppin D; Burg G
Schweiz Med Wochenschr; 1992 Dec; 122(49):1883-8. PubMed ID: 1462149
[TBL] [Abstract][Full Text] [Related]
28. Time to recurrence varies inversely with thickness in clinical stage 1 cutaneous melanoma.
Schultz S; Kane M; Roush R; Miller V; Berd D; Goldman L; Mastrangelo M
Surg Gynecol Obstet; 1990 Nov; 171(5):393-7. PubMed ID: 2237723
[TBL] [Abstract][Full Text] [Related]
29. Late recurrence of malignant melanoma: a report of five cases, a review of the literature and a study of associated factors.
Levy E; Silverman MK; Vossaert KA; Kopf AW; Bart RS; Golomb FM; Levenstein MJ
Melanoma Res; 1991; 1(1):63-7. PubMed ID: 1822771
[TBL] [Abstract][Full Text] [Related]
30. [Follow-up for cutaneous melanoma].
Kettelhack C
Ther Umsch; 2008 Jun; 65(6):335-40. PubMed ID: 18622957
[TBL] [Abstract][Full Text] [Related]
31. Excision guidelines and follow-up strategies in cutaneous melanoma: Facts and controversies.
Leiter U; Eigentler TK; Forschner A; Pflugfelder A; Weide B; Held L; Meier F; Garbe C
Clin Dermatol; 2010; 28(3):311-5. PubMed ID: 20541684
[TBL] [Abstract][Full Text] [Related]
32. Long term follow-up in cutaneous malignant melanoma: the relationship of maximal tumour thickness to disease free survival, disease recurrence and death.
Griffiths RW; Briggs JC
Br J Plast Surg; 1984 Oct; 37(4):507-13. PubMed ID: 6498389
[TBL] [Abstract][Full Text] [Related]
33. Late recurrence of malignant melanoma.
Sweeney WB; James LP; Ghosh BC; Vesoulis Z
Am Fam Physician; 1988 Apr; 37(4):243-7. PubMed ID: 3358347
[TBL] [Abstract][Full Text] [Related]
34. [Pregnancy after malignant melanoma. A follow-up of 23 patients].
Bork K; Bräuninger W; Czarnetzki BM; Addicks B; Paul E; Glitsch M; Noack C
Dtsch Med Wochenschr; 1985 Aug; 110(35):1323-7. PubMed ID: 4028986
[TBL] [Abstract][Full Text] [Related]
35. Malignant melanoma: significance of disease-free interval.
Yarnold JR; Cochrane JP
Br J Radiol; 1980 Nov; 53(635):1068-70. PubMed ID: 7426933
[TBL] [Abstract][Full Text] [Related]
36. Cutaneous melanomas exhibiting unusual biologic behavior.
Shaw HM; Rivers JK; McCarthy SW; McCarthy WH
World J Surg; 1992; 16(2):196-202. PubMed ID: 1561799
[TBL] [Abstract][Full Text] [Related]
37. Changes in survival with clinical stage I malignant melanoma.
Karakousis CP; Kachrimanidis S; Rao U; Emrich LJ
J Surg Oncol; 1987 Mar; 34(3):155-9. PubMed ID: 3821124
[TBL] [Abstract][Full Text] [Related]
38. Tumor thickness as a guide to surgical management of clinical stage I melanoma patients.
Balch CM; Murad TM; Soong SJ; Ingalls AL; Richards PC; Maddox WA
Cancer; 1979 Mar; 43(3):883-8. PubMed ID: 427730
[No Abstract] [Full Text] [Related]
39. Frequency and duration of patient follow-up after treatment of a primary malignant melanoma.
Kelly JW; Blois MS; Sagebiel RW
J Am Acad Dermatol; 1985 Nov; 13(5 Pt 1):756-60. PubMed ID: 4078070
[TBL] [Abstract][Full Text] [Related]
40. Late recurrence of malignant melanoma.
Bale GF
Ann Surg; 1991 Apr; 213(4):372. PubMed ID: 2009021
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
